Showing 1,081 - 1,100 results of 3,363 for search '"UK"', query time: 0.06s Refine Results
  1. 1081
  2. 1082
  3. 1083

    Genomics costing tool: considerations for improving cost-efficiencies through cross scenario comparison by Marco Marklewitz, Alexandr Jaguparov, Aude Wilhelm, Oluwatosin Wuraola Akande, Biran Musul, Angela Lee Poates, Babak Afrough, Ashley Norberg, Noah Clayton Hull, Soudeh Ehsani, Group members of GCT pilot working group, Joanna Salvi Le Garrec, Toni Whistler

    Published 2025-01-01
    “…These institutions are the Association of Public Health Laboratories (APHL), FIND, The Global Fund to Fight AIDS, Tuberculosis and Malaria, the UK Health Security Agency (UKHSA), and the World Health Organization (WHO). …”
    Get full text
    Article
  4. 1084
  5. 1085
  6. 1086

    Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analys... by Gregory Y H Lip, Sally Lee, Brigitta U Monz, Andreas Clemens, Martina Brueckmann

    Published 2012-12-01
    “…Using the CHADS2 method of risk stratification, for the population at intermediate or high risk of stroke and eligible for anticoagulation treatment (CHADS2 ≥1; n=71 493 (85%)), the proportion eligible for inclusion into RE-LY was 74% (95% CI 73.7% to 74.3%; n=52 783), compared with 72% (95% CI 71.7% to 72.3%; n=51 415) for ARISTOTLE and 56% (95% CI 55.6% to 56.4%; n=39 892) for ROCKET-AF.Conclusions Patients enrolled within RE-LY and ARISTOTLE were more reflective of the ‘real-world’ AF population in the UK, in contrast with patients enrolled within ROCKET-AF who were a more narrowly defined group of patients at higher risk of stroke. …”
    Get full text
    Article
  7. 1087

    Development and external validation of the SMA2SH2ERS risk prediction model for aneurysmal subarachnoid haemorrhage in the general population: a population-based prospective cohort... by Kristiina Rannikmäe, Vita M. Klieverik, Jos P. Kanning, Ina L. Rissanen, Amy E. Martinsen, Bendik S. Winsvold, Mirjam I. Geerlings, Ynte M. Ruigrok

    Published 2025-01-01
    “…We aimed to develop and validate a risk prediction model for ASAH in the general population to identify high-risk individuals.Design We used the population-based prospective cohort studies of the United Kingdom (UK) Biobank for model development and the Trøndelag Health (HUNT) Study for model validation.Participants Participants missing data were excluded. …”
    Get full text
    Article
  8. 1088
  9. 1089
  10. 1090

    Exercise-based cardiac rehabilitation for patients with atrial fibrillation receiving catheter ablation: protocol for a feasibility randomised controlled trial (RCT) with embedded... by Gregory Y H Lip, Helen Jones, Mark T Mills, Dhiraj Gupta, Lawrence Foweather, Benjamin JR Buckley, Charlotte Fitzhugh

    Published 2025-01-01
    “…Introduction Atrial fibrillation (AF) affects approximately 2.5% of the UK population, with a risk of 1 in 3–5 individuals after the age of 45 years. …”
    Get full text
    Article
  11. 1091
  12. 1092
  13. 1093
  14. 1094

    East Midlands knee pain multiple randomised controlled trial cohort study: cohort establishment and feasibility study protocol by Michael Doherty, Roshan das Nair, Ana Valdes, Reuben Ogollah, Paul Greenhaff, Bonnie Millar, Michelle Hall, Amy Fuller, Polykarpos Angelos Nomikos, David A Walsh, A Abhishek

    Published 2020-09-01
    “…Introduction Knee pain due to osteoarthritis (OA) is a common cause of disability. The UK National Institute for Health and Care Excellence OA guidelines recommend education, exercise and weight loss advice (if overweight) as core interventions before pharmacological adjuncts. …”
    Get full text
    Article
  15. 1095
  16. 1096

    Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial by Paul Bassett, Tim Weaver, Shoumitro Deb, Mike Crawford, David Sharp, Lina Aimola, Verity Leeson, Mayur Bodani, Lucia Li

    Published 2020-09-01
    “…No statistical comparison was performed between the two study groups.Setting Four neuropsychiatric and neurology outpatient clinics in London and Kent, UK.Participants Our aim was to recruit 50 patients with TBI over 18 months. …”
    Get full text
    Article
  17. 1097
  18. 1098

    Effectiveness and active ingredients of social prescribing interventions targeting mental health: a systematic review by Darren Flynn, Jason Scott, Matthew Cooper, Leah Avery, Linda Errington, Kirsten Ashley, Cara Jordan

    Published 2022-07-01
    “…Objective This study aims to establish the effectiveness and active ingredients of UK-based social prescribing interventions targeting mental health and well-being outcomes.Design Systematic review adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analysies guidelines and a published protocol.Data sources Nine databases were systematically searched up to March 2022.Eligibility criteria Social prescribing interventions in the UK involving adults aged ≥18 years, which reported on mental health outcomes.Data extraction and synthesis Two reviewers extracted data on study characteristics; outcomes; referral pathways; treatment fidelity strategies; person-centredness; intervention development processes and theory-linked behaviour change techniques (BCTs). …”
    Get full text
    Article
  19. 1099
  20. 1100